Breaking News:

Influenza

Add to Favorites Subscribe Share
fbshare-Influenza

Showing results

110 of 606

Flu Preparedness Hearing Opens Opportunities for Vaccine, AMR Action

Infectious Diseases Society of America (IDSA)

Today’s subcommittee hearing on U.S. preparedness and responses for the 2019-2020 flu season offers an important opportunity to examine and act on gaps and challenges exacerbating the public health threats of seasonal influenza outbreaks.

Channels: All Journal News, Government/Law, Public Health, Vaccines, Influenza,

Released:
4-Dec-2019 2:05 PM EST
Newswise: Virtual Reality Could Help Flu Vaccination Rates

Virtual Reality Could Help Flu Vaccination Rates

University of Georgia

Using a virtual reality simulation to show how flu spreads and its impact on others could be a way to encourage more people to get a flu vaccination, according to a study by researchers at the University of Georgia and the Oak Ridge Associated Universities in Oak Ridge, Tennessee

Channels: Healthcare, Infectious Diseases, Public Health, Technology, Vaccines, Influenza, All Journal News,

Released:
3-Dec-2019 12:30 PM EST
Research Results
Newswise: Structurally Designed DNA Star Creates Ultra-Sensitive Test for Dengue Virus

Structurally Designed DNA Star Creates Ultra-Sensitive Test for Dengue Virus

Rensselaer Polytechnic Institute (RPI)

By folding snippets of DNA into the shape of a five-pointed star using structural DNA nanotechnology, researchers have created a trap that captures Dengue virus as it floats in the bloodstream. Once sprung, the trap lights up. in the most sensitive test for the mosquito-borne diseases yet devised.

Channels: All Journal News, Infectious Diseases, Nanotechnology, Influenza, Nature (journal),

Released:
25-Nov-2019 12:10 PM EST
Research Results
uwi-logo.png
  • Embargo expired:
    25-Nov-2019 11:00 AM EST

New flu drug drives drug resistance in influenza viruses

University of Wisconsin-Madison

University of Wisconsin-Madison researchers examined the effects of baloxavir treatment on influenza virus samples collected from patients before and after treatment.

Channels: All Journal News, Children's Health, Drug Resistance, Pharmaceuticals, Influenza, Japan News, Nature (journal),

Released:
19-Nov-2019 1:45 PM EST
Research Results
AANEM Logo Only.png

Study Shows Flu Vaccine Safe For Those With Autoimmune Neuromuscular Disorders

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)

A recent study published in Muscle & Nerve appears to show that the influenza vaccination is safe to use for those with autoimmune neuromuscular disorders.

Channels: All Journal News, Vaccines, Influenza,

Released:
20-Nov-2019 4:05 PM EST
Research Results
Newswise: 4 Essentials for Winter Health and Safety
Released:
15-Nov-2019 8:05 AM EST
Research Results
Newswise: Predictive Science, Inc. Releases Influenza Predictions
Released:
4-Nov-2019 2:05 AM EST
Feature
wau-logo.gif
  • Embargo expired:
    24-Oct-2019 2:00 PM EDT

Flu antibody protects against numerous and wide-ranging strains

Washington University in St. Louis

A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

Channels: All Journal News, Immunology, Infectious Diseases, Public Health, Vaccines, Influenza, Grant Funded News,

Released:
22-Oct-2019 10:05 AM EDT
Research Results

Get your flu shot in October, early November to stay flu-free this season

University of Alabama at Birmingham

Physicians at the University of Alabama at Birmingham want to encourage everyone to get a flu shot between now and early November.

Channels: Immunology, Public Health, Vaccines, Influenza,

Released:
24-Oct-2019 12:05 PM EDT
Research Results

Universal flu vaccine developed at Cornell nearing human trials

Cornell University

A universal influenza vaccine with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.

Channels: Clinical Trials, Immunology, Infectious Diseases, Vaccines, Influenza,

Released:
24-Oct-2019 12:05 PM EDT
Feature

Showing results

110 of 606

Chat now!
3.62389